Abstract
The difference of evidence-based prescription for COVID-19 patients between general medicine and other specialty in Japan is unclear. A retrospective observational study using a hospital-based administrative database was conducted for the differences between departments for prescriptions of glucocorticoids in COVID-19 patients. Of 65,156 patients, 23,348 met indication for glucocorticoids. General medicine physicians in Japan were more likely to prescribe corticosteroids for COVID-19 patients than other departments after its evidence was published (adjusted odds ratio, 1.32; p < 0.001; 95% confidence interval, 1.11-1.56). General medicine physicians were more likely to practice evidence-based care for COVID-19 patients.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
